Commit Biologics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $60M

  • Investors
  • 9

Commit Biologics General Information

Description

Developer of complement-powered immune engagers intended for oncology and autoimmune diseases. The company utilizes a proprietary bispecific complement engager platform and antibody engineering to provide complement-powered immune engagers, bispecific antibodies, oncology immunotherapies, autoimmune disease therapies, B cell depletion candidates, and modular antibody constructs, enabling healthcare providers to eliminate diseased cells through targeted activation of the innate immune system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark
+45 30
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Nordre Fasanvej 215
  • 2000 Frederiksberg
  • Denmark
+45 30

Commit Biologics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Commit Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 17-Nov-2026 $60M Completed Pre-Clinical Trials
5. Seed Round 28-Jan-2025 Completed Pre-Clinical Trials
4. Seed Round 09-May-2024 Completed Startup
3. Grant 14-Feb-2024 Completed Startup
2. Accelerator/Incubator 14-Sep-2021 $589K $589K Completed Startup
1. University Spin-Out 16-Aug-2021 Completed Startup
To view Commit Biologics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Commit Biologics Patents

Commit Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202417958-D0 Engineered complement engaging polypeptides Inactive 06-Dec-2024
GB-202417959-D0 Engineered proteins that engage complement factor and a protein antigen, methods, and uses thereof Inactive 06-Dec-2024
WO-2025229159-A1 Antibodies and antibody constructs against cd20 Pending 01-May-2024
WO-2025229158-A1 Antibodies and antibody constructs against cd38 Pending 01-May-2024
WO-2025229161-A1 Engineered complement engaging polypeptides Pending 01-May-2024 A61P35/00
To view Commit Biologics’s complete patent history, request access »

Commit Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Commit Biologics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
AbbVie Ventures Corporate Venture Capital Minority
Ackermans & van Haaren Growth/Expansion Minority
M Ventures Corporate Venture Capital Minority
Bioqube Ventures Venture Capital Minority
Korys Investments Family Office Minority
You’re viewing 5 of 9 investors. Get the full list »

Commit Biologics FAQs

  • When was Commit Biologics founded?

    Commit Biologics was founded in 2021.

  • Where is Commit Biologics headquartered?

    Commit Biologics is headquartered in Frederiksberg, Denmark.

  • What is the size of Commit Biologics?

    Commit Biologics has 35 total employees.

  • What industry is Commit Biologics in?

    Commit Biologics’s primary industry is Drug Discovery.

  • Is Commit Biologics a private or public company?

    Commit Biologics is a Private company.

  • What is Commit Biologics’s current revenue?

    The current revenue for Commit Biologics is .

  • How much funding has Commit Biologics raised over time?

    Commit Biologics has raised $100M.

  • Who are Commit Biologics’s investors?

    AbbVie Ventures, Ackermans & van Haaren, M Ventures, Bioqube Ventures, and Korys Investments are 5 of 9 investors who have invested in Commit Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process